A special commitment to innovation
Through our deeply ingrained commitment to innovative R&D, Nexus Pharmaceuticals identifies those off-patent and unique molecules that can be developed, improved upon and commercialized so as to advance industry standards and deliver on the critical medical need.
We seek out difficult-to-formulate molecules with significant medical need
We innovate and improve the formulations to advance industry practice
We maintain the highest standards to deliver FDA-approved, life-saving drugs
A special attention to quality
Through our partnerships with leading US-based industry suppliers and manufacturers, privately-held Nexus Pharmaceuticals can ensure consistent, dependable access to the highest-quality products. Our steadfast record of delivery ensures that our critical-need drugs are always available when and where they’re needed most.
Dicyclomine HCL Injection, USP
Prochlorperazine Edisylate Injection, USP
Procainamide HCL Injection, USP
Isoproterenol HCL Injection, USP
News
Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™ (ephedrine sulfate) Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial)
Nexus Pharmaceuticals announced today it has received U.S. Food and Drug Administration (FDA) approval for its New Drug Application (NDA) Emerphed, the first and only premixed ephedrine in a ready-to-use 50 mg/10 mL vial.
Nexus Pharmaceuticals Official Response: Supply Chain Reassurance Amid COVID-19 Outbreak
In light of the recent global outbreak of COVID-19 (Novel Coronavirus), Nexus Pharmaceuticals would like to take the opportunity to provide its partners reassurance on Nexus Pharmaceuticals products’ sourcing and manufacturing.
At Nexus Pharmaceuticals, improving the lives of patients and the people who care for them are at the heart of what we do every day.
Yannick Vidinhouede, Supply Chain Analyst
Find out what we’re about
Discover more and let’s start a conversation
Lincolnshire, IL 60069 United States
